Cigna Group (CI) Stock Forecast & Price Target

$304.14 +3.19 (+1.06%)

Closing price 03:59 PM Eastern

Extended Trading

$302.98 -1.16 (-0.38%)

As of 07:53 PM Eastern

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 19 Analyst Ratings

Sell
0

Hold
2

Buy
17

Based on 19 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 19 analysts, 2 have given a hold rating, 15 have given a buy rating, and 2 have given a strong buy rating for CI.

Consensus Price Target

$374.82
23.24% Upside

According to the 19 analysts' twelve-month price targets for Cigna Group, the average price target is $374.82. The highest price target for CI is $422.00, while the lowest price target for CI is $323.00. The average price target represents a forecasted upside of 23.24% from the current price of $304.14.

Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

CI Analyst Ratings Over Time

Type	Current Forecast 8/22/24 to 8/22/25	1 Month Ago 7/23/24 to 7/23/25	3 Months Ago 5/24/24 to 5/24/25	1 Year Ago 8/23/23 to 8/22/24
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	16 Buy rating(s)	16 Buy rating(s)	13 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$374.82	$380.39	$379.33	$384.86
Forecasted Upside	23.24% Upside	25.02% Upside	19.90% Upside	11.08% Upside
Consensus Rating	Buy	Buy	Buy	Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cigna Group Stock vs. The Competition

Type	Cigna Group	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.79	2.53
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	23.24% Upside	13,202.78% Upside	9.66% Upside
News Sentiment Rating	Positive News See Recent CI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/14/2025	Robert W. Baird 2 of 5 stars	Michael Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$372.00	+29.69%
8/14/2025	Wells Fargo & Company 3 of 5 stars	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$341.00 ➝ $340.00	+17.88%
8/5/2025	Deutsche Bank Aktiengesellschaft 3 of 5 stars	George Hill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	Buy ➝ Buy	$415.00	+53.04%
8/4/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Cassorla Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$388.00 ➝ $350.00	+33.08%
8/1/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$385.00 ➝ $354.00	+32.83%
6/26/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$371.00	+12.45%
6/23/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Langston Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/12/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$385.00 ➝ $405.00	+29.08%
5/5/2025	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
5/5/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$348.00 ➝ $374.00	+12.09%
Get the Latest News and Ratings for CI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cigna Group and its competitors with MarketBeat's FREE daily newsletter.
5/5/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$379.00 ➝ $390.00	+16.04%
4/9/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$360.00 ➝ $384.00	+22.66%
3/20/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$350.00 ➝ $365.00	+13.53%
2/6/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Wilkes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$323.00	+10.24%
2/3/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$410.00 ➝ $390.00	+31.64%
1/31/2025	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$415.00 ➝ $360.00	+21.26%
1/31/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$400.00 ➝ $375.00	+26.31%
1/31/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$410.00 ➝ $380.00	+28.89%
9/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$402.00 ➝ $422.00	+16.25%
8/21/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$435.00 ➝ $438.00	+27.49%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:11 PM ET.

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 20, 2025. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

Here are some ways that investors could benefit from investing in The Cigna Group:

The Cigna Group recently reported strong earnings, with earnings per share surpassing expectations, indicating robust financial health and operational efficiency.
The current stock price is around $300, which may present a buying opportunity for investors looking for value in the healthcare sector.
The company has a solid dividend yield of 2.0%, providing a steady income stream for investors, which is particularly attractive in a low-interest-rate environment.
Analysts have a consensus rating of "Buy" for The Cigna Group, with multiple firms setting price targets above the current stock price, suggesting potential for price appreciation.
The Cigna Group has shown significant revenue growth, with a year-over-year increase of 11.0%, reflecting strong demand for its insurance and related services.

Cigna Group
Bear Case

Investors should be bearish about investing in The Cigna Group for these reasons:

The company's net margin is relatively low at 1.92%, which may indicate challenges in maintaining profitability compared to competitors.
Recent insider selling, where a significant number of shares were sold by an executive, could signal a lack of confidence in the company's short-term performance.
Barclays recently lowered its price target for The Cigna Group, which may reflect concerns about future growth prospects and market conditions.
The payout ratio is 32.97%, which, while sustainable, may limit the company's ability to reinvest in growth opportunities or increase dividends in the future.
With a competitive landscape in the healthcare sector, The Cigna Group may face challenges from emerging players and regulatory changes that could impact its market position.

CI Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $374.82, with a high forecast of $422.00 and a low forecast of $323.00.
: 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last twelve months. There are currently 2 hold ratings, 15 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CI shares.
: According to analysts, Cigna Group's stock has a predicted upside of 23.24% based on their 12-month stock forecasts.
: Over the previous 90 days, Cigna Group's stock had 1 upgrade by analysts.
: Cigna Group has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Guggenheim, Robert W. Baird, Royal Bank Of Canada, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like Cigna Group more than other "medical" companies. The consensus rating for Cigna Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CI) was last updated on 8/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cigna Group (CI) Stock Forecast & Price Target